Noema Pharma is a clinical-stage biopharmaceutical company focused on developing therapies for debilitating central nervous system disorders. The company's pipeline includes mid-clinical-stage therapeutic products designed to improve the lives of patients with conditions such as Persistent Seizures in Tuberous Sclerosis Complex, Severe Pain in Trigeminal Neuralgia, Involuntary Tics associated with Tourette Syndrome, Childhood Onset Fluency Disorder, and other debilitating CNS conditions.

Noema Pharma is a biotech company developing groundbreaking therapies to address the most disabling symptoms in orphan conditions of the brain and nervous system.
Noema’s research and development is focused on understanding and meeting patient needs using our novel therapies.

BioMedPartners

Polaris Partners

Sofinnova Partners

Gilde Healthcare

COM:NOEMAPHARMA

Noema Pharma

Analysis Not Available